Apis Capital Advisors’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.09M | Buy |
116,506
+4,506
| +4% | +$119K | 1.1% | 23 |
|
|
2025
Q1 | $2.7M | Buy |
112,000
+16,000
| +17% | +$386K | 1.31% | 23 |
|
|
2024
Q4 | $3.86M | Buy |
96,000
+19,000
| +25% | +$765K | 2.57% | 12 |
|
|
2024
Q3 | $4.87M | Sell |
77,000
-23,000
| -23% | -$1.46M | 3.39% | 9 |
|
|
2024
Q2 | $5.3M | Buy |
100,000
+30,000
| +43% | +$1.59M | 3.91% | 9 |
|
|
2024
Q1 | $5.74M | Sell |
70,000
-20,000
| -22% | -$1.64M | 4.36% | 5 |
|
|
2023
Q4 | $1.67M | Sell |
90,000
-58,000
| -39% | -$1.08M | 1.76% | 20 |
|
|
2023
Q3 | $1.64M | Buy |
+148,000
| New | +$1.64M | 2.12% | 11 |
|
|
2019
Q3 | $619K | Sell |
90,000
-43,000
| -32% | -$296K | 0.97% | 22 |
|
|
2019
Q2 | $1.1M | Sell |
133,000
-17,000
| -11% | -$141K | 1.65% | 17 |
|
|
2019
Q1 | $1.49M | Buy |
150,000
+30,000
| +25% | +$298K | 1.8% | 11 |
|
|
2018
Q4 | $918K | Buy |
+120,000
| New | +$918K | 1.23% | 20 |
|